← FDA DRUG APPROVALS

FDA ANDA · ANDA078504

BACLOFEN

Sponsor: NORTHSTAR HLTHCARE

APPLICATION
ANDA078504
TYPE
ANDA
ORIGINAL APPROVAL
2009-09-18
LATEST ACTION
2015-04-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BACLOFENPrescription
BACLOFEN 10MG · TABLET · ORAL

Approval history

2015-04-15Labeling · Supplement 5 · standardAP
2015-04-15Labeling · Supplement 4AP
2011-12-28Labeling · Supplement 2AP
2010-03-25Labeling · Supplement 1AP
2009-09-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →